H. Pylori Treatment May Reduce Gastric Cancer Incidence, Death
THURSDAY, Sept. 12, 2019 -- Helicobacter pylori treatment, vitamin supplementation, and garlic supplementation are associated with a reduced risk for gastric cancer mortality, according to a study published online Sept. 11 in The BMJ.
Wen-Qing Li,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 12, 2019 Category: Pharmaceuticals Source Type: news
H. pylori eradication linked to reduced risk of gastric cancer
Gastric cancer incidence and death half as likely over 22 years after short-term H. pylori treatment Related items fromOnMedica Antivirals cut liver cancer risk after hepatitis C Statins might not cut colorectal cancer risk after all Antibiotics, H2RAs and PPIs linked to child obesity Long-term use of PPIs linked to doubling in stomach cancer risk Taking aspirin with a PPI reduces risk of oesophageal cancer (Source: OnMedica Latest News)
Source: OnMedica Latest News - September 11, 2019 Category: UK Health Source Type: news
Diabetes Linked to Increased Risk of Gastric Cancer After H. Pylori Eradication Diabetes Linked to Increased Risk of Gastric Cancer After H. Pylori Eradication
Diabetes appears to increase the risk of gastric cancer after Helicobacter pylori eradication, especially in patients with suboptimal glycemic control, according to a database study.Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 10, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
An Updated Approach to Treatment of H. pylori Infection An Updated Approach to Treatment of H. pylori Infection
This paper summarizes indications for H. pylori testing, available diagnostic tests, and treatment approaches, with a focus on the growing challenges of antibiotic resistance.Southern Medical Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 29, 2019 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news
T2DM Increases Gastric Cancer Risk After H. Pylori Eradication
Targeted screening should be considered in high - risk patients following H. pylori eradication therapy (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 23, 2019 Category: Cancer & Oncology Tags: Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Infections, Internal Medicine, Oncology, Pharmacy, Journal, Source Type: news
T2DM Increases Gastric Cancer Risk After H. Pylori Eradication
TUESDAY, July 23, 2019 -- Type 2 diabetes mellitus increases the risk for gastric cancer after treatment for Helicobacter pylori infection, according to a study published online July 11 in Diabetes Care.
Ka Shing Cheung, M.B.B.S., M.P.H., from The... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 23, 2019 Category: Pharmaceuticals Source Type: news
PPI, H2RA Equally Good at Preventing Bleeding Recurrence in H. Pylori-Negative Ulcers PPI, H2RA Equally Good at Preventing Bleeding Recurrence in H. Pylori-Negative Ulcers
Lansoprazole and famotidine have comparable effects in preventing recurrent idiopathic gastroduodenal ulcer bleeding, a two-year randomized clinical trial shows.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 12, 2019 Category: Consumer Health News Tags: Medscape Today News Source Type: news
Susceptibility-Guided vs Empiric Therapy for H. pylori Susceptibility-Guided vs Empiric Therapy for H. pylori
How do these treatment strategies for H pylori compare in terms of achieving eradication?Alimentary Pharmacology & Therapeutics (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - July 1, 2019 Category: Allergy & Immunology Tags: Gastroenterology Journal Article Source Type: news
How gastric stem cells fight bacteria
Stem cells are not only key players in tissue regeneration, they are also capable of taking direct action against bacteria. This is the finding of a study conducted by researchers from Charité - Universitätsmedizin Berlin and the Max Planck Institute for Infection Biology, which describes what happens during a Helicobacter pylori infection of the human stomach. By actively fighting the colonizing bacteria, gastric stem cells protect themselves against damage that can lead to cancer. (Source: World Pharma News)
Source: World Pharma News - June 25, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
How gastric stem cells fight bacteria
(Charit é - Universit ä tsmedizin Berlin) Stem cells are not only key players in tissue regeneration, they are also capable of taking direct action against bacteria. This is the finding of a study conducted by researchers from Charit é - Universit ä tsmedizin Berlin, which describes what happens during a Helicobacter pylori infection of the human stomach. By actively fighting the colonizing bacteria, gastric stem cells protect themselves against damage that can lead to cancer. Results from this study have been published in Nature Cell Biology. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - June 25, 2019 Category: Biology Source Type: news
H pylori Raises Phosphate Binder Pill Burden in Dialysis H pylori Raises Phosphate Binder Pill Burden in Dialysis
If those with Helicobacter pylori don ' t take a proton pump inhibitor or sodium bicarbonate, they have a higher phosphate binder pill burden, researchers report, between six and nine tablets a day.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 20, 2019 Category: Consumer Health News Tags: Nephrology News Source Type: news
Infection biology: Signs of selection in the stomach
(Ludwig-Maximilians-Universit ä t M ü nchen) Helicobacter pylori, a globally distributed gastric bacterium, is genetically highly adaptable. Microbiologists at Ludwig-Maximilians-Universitaet (LMU) in Munich have now characterized its population structure in individual patients, demonstrating an important role of antibiotics for its within-patient evolution. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 24, 2019 Category: International Medicine & Public Health Source Type: news
Medical News Today: How do cancer-causing bacteria take over our stomachs?
H. pylori live in the stomachs of around 50% of all humans. Despite their prevalence, little is known about how they can survive inside us for a lifetime. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 8, 2019 Category: Consumer Health News Tags: Infectious Diseases / Bacteria / Viruses Source Type: news
RedHill Biopharma Submits New Drug Application for Talicia for H. pylori Infection
TEL-AVIV, Israel and RALEIGH, N.C., May 7, 2019 -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the“Company”), a specialty biopharmaceutical company primarily focused on... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - May 7, 2019 Category: Drugs & Pharmacology Source Type: news
Image of the Day: Gastric Colonies
Scientists map the presence of Helicobacter pylori in the stomach of mice, showing where the bacteria colonize the gastric glands. (Source: The Scientist)
Source: The Scientist - May 6, 2019 Category: Science Tags: Image of the Day Source Type: news
